Use of Immunoferon in the treatment of aphthous recurrent stomatitis in children;Uso del Inmunoferón en el tratamiento de la estomatitis aftosa recurrente en niños

Revista Cubana de Estomatologia

Volumn 43, Issue 3, 2006, Pages

  Castillo, Arturo Castillo ^a,b   Borrego, Amparo Pérez ^a,c   Zamora, María Victoria Guntiñas ^a,c,d  

^a Facultad de Estomatologia   (Cuba)

^b Policlínico Vedado   (Cuba)

^c HOSPITAL PEDIÁTRICO DOCENTE WILLIAM SOLER   (Cuba)

^d Facultad Enrique Cabrera   (Cuba)

Author keywords

Aphthae; Aphthous recurrent stomatitis; Cellular immunodeficiency; Immunomodulators; Oral aphthosis; Oral ulceration

Indexed keywords

EID: 34250345523     PISSN: 00347507     EISSN: 00347507     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Carranza FA. Periodontología Clínica. Buenos Aires: Ed. Mundi; 1978. p. 137-351.
2. Zunt SL. Recurrent aphthous stomatitis. Dermatol Clin 2003;21(1):33-9.
3. Casiglia JM . Recurrent aphthous stomatitis: Etiology, diagnosis, and treatment. Gen Dent 2002;50(2):157-66.
4. Porter S, Scully C. Aphthous ulcers: Recurrent. Clin Evid 2002;(7):1232-8. No abstract available. Update in: Clin Evid 2002;(8):1397-403 .
5. Field EA, Brookes V, Tyldesley WR. Recurrent aphtous ulcerations in children: A review. Int J Pediatric Dent 1992;2:1-10.
6. Pérez A, Guntiñas MV, Glez C. Estomatitis aftosa recurrente. Determinación de marcadores de inmunidad celular. Rev Cubana Estomatol 2002;40(2).
7. Scully C, Gorsky M, Lozada-Nur F . The diagnosis and management of recurrent aphthous stomatitis: A consensus approach. J Am Dent Assoc 2003;134(2):200-7.
8. Lewkowicz N, Lewkowicz P, Kurnatowska A, Banasik M, Glowacka E, Cedzynski M, Swierzko A, Lauk-Puchala B, Tchorzewski H. Innate immune system is implicated in recurrent aphthous ulcer pathogenesis. J Oral Pathol Med 2003;32(8):475-81.
9. Marcos F, Juárez F, Ramos MP, Durán D .Glycophosphopeptical in the treatment of recurrent oral aphthosis. An Med Interna 1994;11(1):44.50.
10. Brieva A, Guerrero A, Alonso-Lebrero JL, Pivel JP. Immunoferon, a glycoconjugate of natural origin, inhibits LPS-induced TNF-alpha production and inflammatory responses. Int Inmunopharmacol 2001;1(11):1979-87.
11. Rojo JM, Rejas MT, Ojeda G, Portoles P, Barasoain I . Enhancement of lymphocyte proliferation, interleukin-2 production and NK activity by inmunoferon (AM-3), a fungal immunomodulator: Variations in normal and immunosuppressed mice. Int J Immunopharmacol 1986;8(6):593-7.
12. Prieto A, Reyes E, Bernstein ED, Martínez B, Monserrat J, Izquierdo JL, Callol L, de Lucas P, Alvarez-Sala R, Alvarez-Sala JL, Villarrubia VG, Alvarez-Mon M. Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (inmunoferon). Am J Respir Crit Care Med 2001;163(7):1578-83.
13. Pérez-García R, Pérez-García A, Verbeelen D, Bernstein ED, Villarrubia VG, Alvarez-Mon M . AM3 (Inmunoferon) as an adjuvant to hepatitis B vaccination in hemodialysis patients. Kidney Int 2002;61(5):1845-52.
14. Camacho F, Elorza FL, Ortega M, Elorza MA, Sada G, Villarrubia VG . AM3 (a biological response modifier) in the treatment of recurrent aphthous stomatitis. Clinical evaluation and preliminary studies on NK (CD16) cells and their pathogenic role in the syndrome. Rev Clin Esp 1991;188(8):403-8.
15. Eisen D, Lynch D P . Selecting topical and systemic agents for recurrent aphthous stomatitis. Cutis 2001;68(3):201-6.
16. Stoopler ET, Sollectio TP. Recurrent aphthous stomatitis. Update for the general practitioner. N Y State Dent J 2003;69(2):27-9.
17. Camacho F, Ortega M, Elorza F. Glycophosphopeptical in the treatment of recurrent oral aphthae. An Med Intern 1995;12(14):204.
18. F r itscher AM, Cherubini K, Chies J, Dias A C . Association between Helicobacter pylori and recurrent aphthous stomatitis in children and adolescents. J Oral Pathol Med 2004;33(3):129-33.
19. Moya P, Balzeras F, Barasoain I, et al. Inmunoferón (AM3) enhaces the activities of early-type interferón inducers and natural killer cells. Inmunopharmacol Inmunotoxicol 1987;9:243-56.
20. Villarrubia VG, Sada G, Luini W, Sozzani S, Spreafico F. Restauración por AM3 de las actividades citotóxicas antitumorales de células NK y macrófagos en animales inmunocomprometidos. Oncología 1987;10:283-91.
21. Birek C . Herpesvirus-induced diseases: oral manifestations and current treatment options. J Calif Dent Assoc 2000;28(12):911-21.